NASDAQ:SCPS

Scopus Biopharma Stock Forecast, Price & News

$12.92

-0.52 (-3.87 %)

(As of 01/21/2021 12:00 AM ET)

Add

Compare

Today's Range

$12.80

Now: $12.92▼

$13.56

50-Day Range N/A

52-Week Range

$5.34

Now: $12.92▼

$47.86

Volume80,147 shs

Average Volume116,504 shs

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Scopus BioPharma Inc. develops therapeutics drugs targeting the endocannabinoid system. The company was formerly known as Project18 Inc. and changed its name to Scopus BioPharma Inc. in December, 2017. The company was incorporated in 2017 and is based in New York, New York.

Overall MarketRank^™

0.00 out of 5 stars

Medical Sector

1892nd out of 1,926 stocks

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Scopus Biopharma.

0.0 Community Rank

Outperform Votes
Scopus Biopharma has received 0 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Scopus Biopharma has received 1 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Scopus Biopharma has received 100.00% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Scopus Biopharma and other stocks. Vote “Outperform” if you believe SCPS will outperform the S&P 500 over the long term. Vote “Underperform” if you believe SCPS will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Scopus Biopharma does not currently pay a dividend.
Dividend Growth
Scopus Biopharma does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Scopus Biopharma insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

Industry, Sector and Symbol

Stock Exchange NASDAQ

Industry N/A

Sub-IndustryN/A

SectorMedical

Current SymbolNASDAQ:SCPS

Previous Symbol

CUSIPN/A

CIKN/A

WebN/A

Phone212-479-2513

Employees1

Debt

Debt-to-Equity RatioN/A

Current RatioN/A

Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual SalesN/A

Price / SalesN/A

Cash FlowN/A

Price / Cash FlowN/A

Book ValueN/A

Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Outstanding SharesN/A

Market CapN/A

Next Earnings DateN/A

OptionableNot Optionable

$12.92

-0.52 (-3.87 %)

(As of 01/21/2021 12:00 AM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive SCPS News and Ratings via Email

Sign-up to receive the latest news and ratings for SCPS and its competitors with MarketBeat's FREE daily newsletter.

Scopus Biopharma (NASDAQ:SCPS) Frequently Asked Questions

What stocks does MarketBeat like better than Scopus Biopharma?

Wall Street analysts have given Scopus Biopharma a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Scopus Biopharma wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

What is Doug Parker's approval rating as Scopus Biopharma's CEO?

1,448 employees have rated Scopus Biopharma CEO Doug Parker on Glassdoor.com. Doug Parker has an approval rating of 60% among Scopus Biopharma's employees. This puts Doug Parker in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Scopus Biopharma's key competitors?

Some companies that are related to Scopus Biopharma include (BUX) (BUX), (CHV) (CHV), (CSI) (CSI), (PHGI) (PHGI), (PREV) (PREV), (THCX.V) (THCX), 12144 (IME), 1300SMILES Limited (ONT.AX) (ONT), 138267 (COM.TO) (COM), 17031 (MYM), 1933 Industries (TGIFF), 28896 (BAMM), 31444 (GLH), 438280 (ACG) and 815446 (HC).
View all of SCPS's competitors.

Who are Scopus Biopharma's key executives?

Scopus Biopharma's management team includes the following people:

Dr. Morris C. Laster, Co-Chairman & CEO (Age 55)
Mr. Robert J. Gibson, Vice Chairman, Sec. & Treasurer
Mr. Daniel J. Politzer C.F.A., CFO & COO (Age 51)
Mr. Ira Scott Greenspan, Sr. Advisor & Director (Age 61)
Dr. Aharon Schwartz, Sr. Advisor (Age 77)
Mr. David Silberg, Sr. Advisor (Age 71)

What is Scopus Biopharma's stock symbol?

Scopus Biopharma trades on the NASDAQ under the ticker symbol "SCPS."

When does Scopus Biopharma's quiet period expire?

Scopus Biopharma's quiet period expires on Monday, January 25th. Scopus Biopharma had issued 500,000 shares in its IPO on December 16th. The total size of the offering was $2,750,000 based on an initial share price of $5.50. During Scopus Biopharma's quiet period, underwriters and any insiders that worked on the IPO are prevented from issuing any research reports for the company because of regulations issued by the Securities and Exchange Commission. Following the expiration of the company's quiet period, it's expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.

How do I buy shares of Scopus Biopharma?

Shares of SCPS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Scopus Biopharma's stock price today?

One share of SCPS stock can currently be purchased for approximately $12.92.

How can I contact Scopus Biopharma?

The company can be reached via phone at 212-479-2513.

This page was last updated on 1/22/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Scopus Biopharma Stock Forecast, Price & News

Adding

Adding

Adding Scopus Biopharma Inc.

MarketRank™

Overall MarketRank™